Concepedia

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

Elizabeth Rakoczy, Chooi‐May Lai, Aaron L. Magno, Matthew E. Wikström, Martyn A. French, Cora Pierce, Steven D. Schwartz, Mark S. Blumenkranz, Thomas W. Chalberg, Mariapia A. Degli‐Esposti,

The Lancet · 2015 · 188 citations · 44 references

DOIFull text

Open access

Concepts

References

44

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

, , +12

Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates

Archives of Ophthalmology · 2004 · 2.6K citations · Full text

, , +17

Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis

James Bainbridge, Alexander J. Smith, Susie S. Barker et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

, , +15

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text

, , +12

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

R.L. Kendall, Kenneth A. Thomas · Proceedings of the National Academy of Sciences · 1993 · 1.4K citations

, , +13